. The article concerns interactions between immunoglobulin A and recombinant P6, P7, P8 polypeptides, designed on the basis of externally localized Bac protein of the Group B streptococci, possessing IgA-binding activity.There is a current demand for ...
A. S. Korzhueva +5 more
doaj +1 more source
TFPI-2 Protects Against Gram-Negative Bacterial Infection
Tissue factor pathway inhibitor-2 (TFPI-2) has previously been characterized as an endogenous anticoagulant. TFPI-2 is expressed in the vast majority of cells, mainly secreted into the extracellular matrix.
Mohamad N. Ali +12 more
doaj +1 more source
Background & Aims: Environmental enteric dysfunction (EED), a chronic diffuse inflammation of the small intestine, is associated with stunting in children in the developing world.
Jinsheng Yu +9 more
doaj +1 more source
Allosteric inhibition of IgE–FcεRI interactions by simultaneous targeting of IgE F(ab’)2 epitopes
Immunoglobulin E (IgE) plays pivotal roles in allergic diseases through interaction with a high-affinity receptor (FcεRI). We established that Fab fragments of anti-IgE antibodies (HMK-12 Fab) rapidly dissociate preformed IgE-FcεRI complexes in a ...
Takao Hirano +6 more
doaj +1 more source
Human immunoglobulin A (IgA), comprising the isotypes IgA1 and IgA2, protects ~400 m2 of mucosal surfaces against microbial infections but can also lead to aberrant IgA deposits that cause disease. Certain bacteria have evolved peptidases that cleave the
Juan Sebastián Ramírez-Larrota +4 more
doaj +1 more source
One-step cleavage and purification: a bifunctional IdeS-Protein A fusion protein for on-column generation of antibody fragments. [PDF]
Zhang T, Liao H, Teng CB, Wang C.
europepmc +1 more source
The Promise of Single-Domain Antibodies as Ocular Therapeutics: A Narrative Review. [PDF]
Jakobsen TS +6 more
europepmc +1 more source
Fab-Fc and Fab-Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG<sub>1</sub> antibodies. [PDF]
Heisler J +5 more
europepmc +1 more source
Nomenclature of therapies in inflammatory bowel disease: A journey through time and terminology. [PDF]
Colwill M +4 more
europepmc +1 more source
Complete and Rapid NMR Characterization of Therapeutic Monoclonal Antibodies via Differential Labeling of Fab Fragments in <i>Escherichia coli</i>. [PDF]
Gagné D, Aubin Y.
europepmc +1 more source

